KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS aims at providing people and patients with highly effective and safe products based on biomolecules.
International patent – 11.09.2019
KYLYS is pleased to announce that its main patent application filed under the PCT convention recently entered the national phases. This is an important step toward...
More Information
Bioinnovation day – 15.11.2018
We are very proud to have been selected by the BioInnovation Day 2018 organization to present our project HA Pearls. The 8th edition of BioInnovation Day took place on...
More Information
Exclusive worldwide license – 08.09.2017
KYLYS is assigned exclusive worldwide rights by University of Geneva on an innovative technology based on hyaluronic acid (HA). HA, a naturally occurring biocompatible...
More Information
Controlled Release Society (CRS) 44th Annual Meeting & Exposition – 16.07.2017
We have presented our technology to a prestigious international meeting: the 44th Annual Meeting & Exposition of the Controlled Release Society in Boston,...
More Information
International Conference on Advances in Basic, Applied and Clinical Science of Hyaluronan – 11.06.2017
We have presented our technology to the most important world hyaluronan conference in Cleveland, Ohio, United States.
More Information
From researcher to entrepreneur – 02.05.2017
We have presented our experience “from researcher to entrepreneur” to a packed audience at the Centre Médical Universitaire on Tuesday, 2nd of May 2017,...
More Information
First Innovation Award & Startup Award – 20.10.2016
Every year since 2007 the University Hospital of Geneva (HUG), in partnership with the Geneva Faculty of Medicine, has organized Innovation Days where a...
More Information